Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-002281
Filing Date
2015-01-14
Accepted
2015-01-14 17:22:03
Documents
1
Period of Report
2015-01-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v398752_4.html 4  
1 OWNERSHIP DOCUMENT v398752_4.xml 4 4185
  Complete submission text file 0001144204-15-002281.txt   5998
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DANCE BIOPHARM INC. 150 NORTH HILL DRIVE, SUITE 24 BRISBANE CA 94005
Business Address
Huffman Donald D (Reporting) CIK: 0001501222 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55016 | Film No.: 15527856